Standard BioTools and SomaLogic Planned Merger

Illumina Acquires SomaLogic from Standard BioTools

January 30, 2026

Healthcare Services

Illumina, Inc. completed its acquisition of SomaLogic, adding data-driven proteomics technology to expand its multiomics portfolio. The deal was for $350 million in upfront cash at closing, plus up to $75 million in near-term performance-based milestones/royalties, with Illumina expecting to fund the transaction with cash on hand.

Standard BioTools Acquires Sengenics from Summa Equity

November 21, 2024

Biotechnology

Standard BioTools Inc. has acquired Sengenics Corporation Pte Ltd, a Summa Equity portfolio company, to broaden its proteomics and antibody‑profiling capabilities. The deal will integrate Sengenics' KREX™ immunoproteomics and i-OME™ Discovery platform with Standard BioTools' SomaScan/proteomics offerings to enhance biomarker discovery and accelerate drug development.

VaLogic Bio Acquires Superior Laboratory Services, Inc.

August 1, 2024

Healthcare Services

VaLogic Bio, a Frederick, Maryland–based provider of GMP compliance and laboratory technology solutions, has acquired Superior Laboratory Services, Inc. (SLSI), a Pasadena, Texas lab design, construction and certification firm. The acquisition adds SLSI's two decades of laboratory design and USP/pharmaceutical laboratory expertise to VaLogic's service offerings and will keep the Pasadena office operational under VaLogic ownership.

LabVantage Solutions and Biomax Informatics Merge

October 11, 2022

Software

LabVantage Solutions and Germany-based Biomax Informatics have closed a merger agreement to combine their laboratory informatics, knowledge-management and semantic-search capabilities. The combination brings together LabVantage’s LIMS/ELN/SDMS platform with Biomax’s decision-support and knowledge-management software to expand product and service offerings for life sciences, biomanufacturing and healthcare customers.

SPT Labtech Acquires BioMicroLab

February 15, 2021

Medical Devices

SPT Labtech has acquired BioMicroLab, a Northern California-based provider of benchtop robotics and laboratory automation systems. The acquisition expands SPT Labtech's sample management and automation capabilities, creating a more comprehensive end-to-end solution for life science laboratories.

Alexion, AstraZeneca Rare Disease Acquires LogicBio Therapeutics

November 16, 2022

Biotechnology

Alexion, AstraZeneca Rare Disease completed its acquisition of LogicBio Therapeutics, a Lexington, Massachusetts-based genomic medicine company. The deal was implemented through a cash tender offer and a merger of an Alexion subsidiary with LogicBio, with LogicBio becoming a wholly owned subsidiary of Alexion.